The impact of differential uptake of HPV vaccine by sexual risks on health inequalities: A model-based analysis

Vaccine

Volumn 31, Issue 13, 2013, Pages 1740-1747

  Malagón, Talía ^a,b   Joumier, Véronique ^a   Boily, Marie Claude ^a,c   Van de Velde, Nicolas ^a,b   Drolet, Mélanie ^a,b   Brisson, Marc ^a,b,c  

^a University Laval   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Health inequality; Human papillomavirus (HPV); Mathematical model; Sexual activity; Vaccine

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; CALIBRATION; CHILD; DRUG UPTAKE; FEMALE; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MALE; PAPILLOMAVIRUS INFECTION; PREDICTION; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY ANALYSIS; SEXUAL BEHAVIOR; SIMULATION; UNCERTAINTY; VACCINATION; VIRUS TRANSMISSION;

ADOLESCENT; CANADA; CHILD; FEMALE; HUMANS; MALE; MODELS, STATISTICAL; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; SEXUAL BEHAVIOR; VACCINATION; YOUNG ADULT;

EID: 84875259253     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.01.026     Document Type: Article

References (57)

1. Baseman J.G., Koutsky L.A. The epidemiology of human papillomavirus infections. J Clin Virol 2005, 32(Suppl. 1):S16-S24. Epub 2005/03/09. PubMed PMID: 15753008. 10.1016/j.jcv.2004.12.008.
2. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348(6):518-527. Epub 2003/02/07. PubMed PMID: 12571259. 10.1056/NEJMoa021641.
3. De Vuyst H., Clifford G.M., Nascimento M.C., Madeleine M.M., Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009, 124(7):1626-1636. Epub 2008/12/31. PubMed PMID: 19115209. 10.1002/ijc.24116.
4. Backes D.M., Kurman R.J., Pimenta J.M., Smith J.S. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control 2009, 20(4):449-457. Epub 2008/12/17. PubMed PMID: 19082746. 10.1007/s10552-008-9276-9.
5. Kreimer A.R., Clifford G.M., Boyle P., Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 2005, 14(2):467-475. Epub 2005/03/01. PubMed PMD: 15734974. 10.1158/1055-9965.EPI-04-0551.
6. Kahn J.A., Lan D., Kahn R.S. Sociodemographic factors associated with high-risk human papillomavirus infection. Obstet Gynecol 2007, 110(1):87-95. Epub 2007/07/03. PubMed PMID: 17601901. 10.1097/01.AOG. 0000266984.23445.9c.
7. Singh G.K., Miller B.A., Hankey B.F., Edwards B.K. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000. Cancer 2004, 101(5):1051-1057. Epub 2004/08/27. PubMed PMID: 15329915. 10.1002/cncr.20467.
8. Dunne E.F., Unger E.R., Sternberg M., McQuillan G., Swan D.C., Patel S.S., et al. Prevalence of HPV infection among females in the United States. JAMA 2007, 297(8):813-819. Epub 2007/03/01. PubMed PMID: 17327523. 10.1001/jama.297.8.813.
9. Downs L.S., Smith J.S., Scarinci I., Flowers L., Parham G. The disparity of cervical cancer in diverse populations. Gynecol Oncol 2008, 109(Suppl. 2):S22-S30. Epub 2008/06/14. PubMed PMID: 18482555, S22-S30. 10.1016/j.ygyno.2008.01.003.
10. Cervical carcinoma and sexual behavior: collaborative reanalysis of individual data on 15,461 women with cervical carcinoma and 29,164 women without cervical carcinoma from 21 epidemiological studies. Cancer Epidemiol Biomarkers Prev 2009, 18(4):1060-1069. Epub 2009/04/02. PubMed PMID: 19336546. 10.1158/1055-9965.EPI-08-1186.
11. Heck J.E., Berthiller J., Vaccarella S., Winn D.M., Smith E.M., Shan'gina O., et al. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int J Epidemiol 2010, 39(1):166-181. Epub 2009/12/22. PubMed PMID: 20022926; PubMed Central PMCID: PMC2817092. 10.1093/ije/dyp350.
12. Melbye M., Rabkin C., Frisch M., Biggar R.J. Changing patterns of anal cancer incidence in the United States, 1940-1989. Am J Epidemiol 1994, 139(8):772-780. Epub 1994/04/15. PubMed PMID: 8178790.
13. Santelli J.S., Lowry R., Brener N.D., Robin L. The association of sexual behaviors with socioeconomic status, family structure, and race/ethnicity among US adolescents. Am J Public Health 2000, 90(10):1582-1588. Epub 2000/10/13. PubMed PMID: 11029992; PubMed Central PMCID: PMC1446372.
14. Halpern C.T., Haydon A.A. Sexual timetables for oral-genital, vaginal, and anal intercourse: sociodemographic comparisons in a nationally representative sample of adolescents. Am J Public Health 2012, 102(6):1221-1228. Epub 2012/05/11. PubMed PMID: 22571710; PubMed Central PMCID: PMC3394539. 10.2105/AJPH. 2011.300394.
15. Lammers C., Ireland M., Resnick M., Blum R. Influences on adolescents' decision to postpone onset of sexual intercourse: a survival analysis of virginity among youths aged 13 to 18 years. J Adolesc Health 2000, 26(1):42-48. PubMed PMID: 10638717.
16. Cubbin C., Vesely S.K., Braveman P.A., Oman R.F. Socioeconomic factors and health risk behaviors among adolescents. Am J Health Behav 2011, 35(1):28-39. PubMed PMID: 20950156.
17. Cubbin C., Santelli J., Brindis C.D., Braveman P. Neighborhood context and sexual behaviors among adolescents: findings from the national longitudinal study of adolescent health. Perspect Sex Reprod Health 2005, 37(3):125-134. PubMed PMID: 16150660. 10.1363/psrh.37.125.05.
18. Jensen K.E., Munk C., Sparen P., Tryggvadottir L., Liaw K.L., Dasbach E., et al. Women's sexual behavior. Population-based study among 65,000 women from four Nordic countries before introduction of human papillomavirus vaccination. Acta Obstet Gynecol Scand 2011, 90(5):459-467. PubMed PMID: 21306319. 10.1111/j.1600-0412.2010.01066.x.
19. Samandari G., Speizer I.S. Adolescent sexual behavior and reproductive outcomes in Central America: trends over the past two decades. Int Perspect Sex Reprod Health 2010, 36(1):26-35. PubMed PMID: 20403803; PubMed Central PMCID: PMC2895925. 10.1363/ipsrh.36.026.10.
20. Buttmann N., Nielsen A., Munk C., Liaw K.L., Kjaer S.K. Sexual risk taking behaviour: prevalence and associated factors. A population-based study of 22,000 Danish men. BMC Public Health 2011, 11:764. PubMed PMID: 21975163; PubMed Central PMCID: PMC3206478. 10.1186/1471-2458-11-764.
21. Eaton D.K., Kann L., Kinchen S., Shanklin S., Flint K.H., Hawkins J., et al. Youth risk behavior surveillance - United States, 2011. MMWR Surveill Summ 2012, 61(4):1-162. PubMed PMID: 22673000.
22. Martinez G., Copen C., Abma J. Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2006-2010 National Survey of Family Growth. Vital Health Stat 2011, 23(31). Available from: http://www.cdc.gov/nchs/nsfg/nsfg_products.htm.
23. de Sanjose S., Bosch F.X., Munoz N., Shah K. Social differences in sexual behaviour and cervical cancer. IARC Sci Publ 1997, 138:309-317. Epub 1997/01/01. PubMed PMID: 9353671.
24. Laumann E.O., Youm Y. Racial/ethnic group differences in the prevalence of sexually transmitted diseases in the United States: a network explanation. Sex Transm Dis 1999, 26(5):250-261. Epub 1999/05/20. PubMed PMID: 10333277.
25. Aral S.O., Adimora A.A., Fenton K.A. Understanding and responding to disparities in HIV and other sexually transmitted infections in African Americans. Lancet 2008, 372(9635):337-340. Epub 2008/07/29. PubMed PMID: 18657713. 10.1016/S0140-6736(08)61118-6.
26. Valois R.F., Oeltmann J.E., Waller J., Hussey J.R. Relationship between number of sexual intercourse partners and selected health risk behaviors among public high school adolescents. J Adolesc Health 1999, 25(5):328-335. Epub 1999/11/07. PubMed PMID: 10551663.
27. Spring B., Moller A.C., Coons M.J. Multiple health behaviours: overview and implications. J Public Health (Oxf) 2012, 34(Suppl. 1):i3-i10. Epub 2012/03/06. PubMed PMID: 22363028; PubMed Central PMCID: PMC3284863. 10.1093/pubmed/fdr111.
28. Mills L.A., Vanderpool R.C., Crosby R.A. Sexually related behaviors as predictors of HPV vaccination among young rural women. J Womens Health (Larchmt) 2011, 20(12):1909-1915. Epub 2011/12/06. PubMed PMID: 22136319. 10.1089/jwh.2011.3000.
29. Liddon N.C., Leichliter J.S., Markowitz L.E. Human papillomavirus vaccine and sexual behavior among adolescent and young women. Am J Prev Med 2012, 42(1):44-52. Epub 2011/12/20. PubMed PMID: 22176845. 10.1016/j.amepre.2011.09.024.
30. Manhart L.E., Burgess-Hull A.J., Fleming C.B., Bailey J.A., Haggerty K.P., Catalano R.F. HPV vaccination among a community sample of young adult women. Vaccine 2011, 29(32):5238-5244. Epub 2011/06/07. PubMed PMID: 21640775; PubMed Central PMCID: PMC3138805. 10.1016/j.vaccine.2011.05.024.
31. Roberts S.A., Brabin L., Stretch R., Baxter D., Elton P., Kitchener H., et al. Human papillomavirus vaccination and social inequality: results from a prospective cohort study. Epidemiol Infect 2011, 139(3):400-405. Epub 2010/03/26. PubMed PMID: 20334731. 10.1017/S095026881000066X.
32. Chao C., Slezak J.M., Coleman K.J., Jacobsen S.J. Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health 2009, 99(6):1137-1142. Epub 2009/04/18. PubMed PMID: 19372507; PubMed Central PMCID: PMC2679804. 10.2105/AJPH. 2008.147876.
33. Lefevere E., Hens N., Theeten H., Van den Bosch K., Beutels P., De Smet F., et al. Like mother, like daughter? Mother's history of cervical cancer screening and daughter's Human Papillomavirus vaccine uptake in Flanders (Belgium). Vaccine 2011, 29(46):8390-8396. Epub 2011/08/23. PubMed PMID: 21856360. 10.1016/j.vaccine.2011.08.039.
34. Steens A., Wielders C.C., Bogaards J.A., Boshuizen H.C., de Greeff S.C., de Melker H.E. Association between human papillomavirus vaccine uptake and cervical cancer screening in the Netherlands: Implications for future impact on prevention. Int J Cancer 2012, Epub 2012/06/13. PubMed PMID: 22689326. 10.1002/ijc.27671.
35. Anhang Price R., Koshiol J., Kobrin S., Tiro J.A. Knowledge and intention to participate in cervical cancer screening after the human papillomavirus vaccine. Vaccine 2011, 29(25):4238-4243. Epub 2011/04/09. PubMed PMID: 21473953; PubMed Central PMCID: PMC3105777. 10.1002/ijc.27671.
36. Pruitt S.L., Schootman M. Geographic disparity, area poverty, and human papillomavirus vaccination. Am J Prev Med 2010, 38(5):525-533. Epub 2010/04/23. PubMed PMID: 20409501; PubMed Central PMCID: PMC3259737. 10.1016/j.amepre.2010.01.018.
37. Bach P.B. Gardasil: from bench, to bedside, to blunder. Lancet 2010, 375(9719):963-964. Epub 2010/03/23. PubMed PMID: 20304226. 10.1016/S0140-6736(09)62029-8.
38. National and state vaccination coverage among adolescents aged 13-17 years - United States, 2011. MMWR Morb Mortal Wkly Rep 2012, 61:671-677. Epub 2012/08/31. PubMed PMID: 22932301.
39. Dempsey A., Cohn L., Dalton V., Ruffin M. Worsening disparities in HPV vaccine utilization among 19-26 year old women. Vaccine 2011, 29(3):528-534. Epub 2010/11/06. PubMed PMID: 21050904; PubMed Central PMCID: PMC3013617. 10.1016/j.vaccine.2010.10.051.
40. Ford J.L. Racial and ethnic disparities in human papillomavirus awareness and vaccination among young adult women. Public Health Nurs 2011, 28(6):485-493. Epub 2011/11/19. PubMed PMID: 22092458. 10.1111/j.1525-1446.2011.00958.x.
41. Jain N., Euler G.L., Shefer A., Lu P., Yankey D., Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Prev Med 2009, 48(5):426-431. Epub 2008/12/23. PubMed PMID: 19100762. 10.1016/j.ypmed.2008.11.010.
42. Lefevere E., Hens N., De Smet F., Van Damme P. Dynamics of HPV vaccination initiation in Flanders (Belgium) 2007-2009: a Cox regression model. BMC Public Health 2011, 11:470. Epub 2011/06/16. PubMed PMID: 21672202; PubMed Central PMCID: PMC3125379. 10.1186/1471-2458-11-470.
43. Tiro J.A., Tsui J., Bauer H.M., Yamada E., Kobrin S., Breen N., et al. Correlates of the Human Papillomavirus Vaccine Among Adolescent Girls and Young Adult Women: An Analysis of the 2007 California Health Interview Survey. J Womens Health (Larchmt) 2012, Epub 2012/03/17. PubMed PMID: 22420920. 10.1089/jwh.2011.3284.
44. Spriggs A.L., Halpern C.T. Timing of sexual debut and initiation of postsecondary education by early adulthood. Perspect Sex Reprod Health 2008, 40(3):152-161. PubMed PMID: 18803797. 10.1363/4015208.
45. Mott F.L., Fondell M.M., Hu P.N., Kowaleski-Jones L., Menaghan E.G. The determinants of first sex by age 14 in a high-risk adolescent population. Fam Plann Perspect 1996, 28(1):13-18. PubMed PMID: 8822410.
46. Munoz N., Mendez F., Posso H., Molano M., van den Brule A.J., Ronderos M., et al. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 2004, 190(12):2077-2087. PubMed PMID: 15551205. 10.1086/425907.
47. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., Unger E.R., et al. Quadrivalent Human Papillomavirus Vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007, 56(RR-2):1-24. PubMed PMID: 17380109.
48. Renton A., Whitaker L., Ison C., Wadsworth J., Harris J.R. Estimating the sexual mixing patterns in the general population from those in people acquiring gonorrhoea infection: theoretical foundation and empirical findings. J Epidemiol Community Health 1995, 49(2):205-213. Epub 1995/04/01. PubMed PMID: 7798052; PubMed Central PMCID: PMC1060109.
49. Garnett G.P., Hughes J.P., Anderson R.M., Stoner B.P., Aral S.O., Whittington W.L., et al. Sexual mixing patterns of patients attending sexually transmitted diseases clinics. Sex Transm Dis 1996, 23(3):248-257. Epub 1996/05/01. PubMed PMID: 8724517.
50. Schmidt H., Public health ethics. In: Editor-in-Chief: Ruth C, editor. Encyclopedia of applied ethics. 2nd ed. San Diego: Academic Press; 2012. p. 685-95.
51. Van de Velde N., Brisson M., Boily M.C. Understanding differences in predictions of HPV vaccine effectiveness: a comparative model-based analysis. Vaccine 2010, 28(33):5473-5484. Epub 2010/06/25. PubMed PMID: 20573580. 10.1016/j.vaccine.2010.05.056.
52. Keenan K., Hipwell A., Stepp S. Race and sexual behavior predict uptake of the human papillomavirus vaccine. Health Psychol 2012, 31(1):31-34. Epub 2012/01/11. PubMed PMID: 22229933; PubMed Central PMCID: PMC3313833. 10.1037/a0026812.
53. Taylor L.D., Hariri S., Sternberg M., Dunne E.F., Markowitz L.E. Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008. Prev Med 2011, 52(5):398-400. Epub 2010/11/27. PubMed PMID: 21108962. 10.1016/j.ypmed.2010.11.006.
54. Liddon N.C., Hood J.E., Leichliter J.S. Intent to receive HPV vaccine and reasons for not vaccinating among unvaccinated adolescent and young women: findings from the 2006-2008 National Survey of Family Growth. Vaccine 2012, 30(16):2676-2682. Epub 2012/02/22. PubMed PMID: 22342548. 10.1016/j.vaccine.2012.02.007.
55. Brisson M., Van de Velde N., Boily M.C. Economic evaluation of human papillomavirus vaccination in developed countries. Public Health Genomics 2009, 12(5/6):343-351. Epub 2009/08/18. PubMed PMID: 19684446. 10.1159/000214924.
56. Kim J.J. Weighing the benefits and costs of HPV vaccination of young men. N Engl J Med 2011, 364(5):393-395. 10.1056/NEJMp1012246.
57. Silvia de Sanjosé, Mireia Diaz, Xavier Castellsagué, Gary Clifford, Laia Bruni, Nubia Muñoz, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 2007, 7(7):453-460.